Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of AR106614A2publicationCriticalpatent/AR106614A2/es
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Una composición farmacéutica sólida que comprende (a) el compuesto hemi-pentahidrato de [3-((1S,3R)-1-bifenil-4-ilmetil-3-etoxi-carbonil-1-butil-carbamoil)-propionato-(S)-3’-metil-2’-(pentanoil-{2’’-(tetrazol-5-ilato)-bifenil-4’-ilmetil}-amino)-butirato] de trisodio; y (b) por lo menos un aditivo farmacéuticamente aceptable.
[hemi-pentahidrato de [3-((1s,3r)-1-bifenil-4-ilmetil-3-etoxi-carbonil-1-butil-carbamoil)-propionato-(s)-3’-metil-2’-(pentanoil-{2’’-(tetrazol-5-ilato)-bifenil-4’-ilmetil}-amino)-butirato] de trisodio
[hemi-pentahidrato de [3-((1s,3r)-1-bifenil-4-ilmetil-3-etoxi-carbonil-1-butil-carbamoil)-propionato-(s)-3’-metil-2’-(pentanoil-{2’’-(tetrazol-5-ilato)-bifenil-4’-ilmetil}-amino)-butirato] de trisodio
Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler